Latest News - Galderma

Thursday, July 26, 2018

Survey: Most Women Think Their Hands Make Them Look Old

Just shy of 80 percent of women ages 40 and older wish they could change the way their hands look, according to Nestlé Skin Health’s 'Face Your Hands' survey. Additionally, 60 …

Read the full story

Friday, July 20, 2018

Breaking News: Galderma Skinpact Awards Deadline Extended!

The new deadline for the Galderma Skinpact Awards is July 31, 2018. The awards are a social responsibility program by Galderma International in partnership with the Canadian Dermatology Association…

Read the full story

Wednesday, July 11, 2018

Fourth Generation Retinoid Shows Promise in Acne Trials

New research reveals that trifarotene, a fourth-generation retinoid with potent and selective activity against only one particular retinoic acid receptor, may have an improved efficacy and safety prof…

Read the full story

Friday, June 08, 2018

Galderma Global Survey Assesses Burden of Rosacea

    Recently released findings from Galderma’s global survey on the true burden of rosacea suggest a need for dermatologists and doctors to proactively open a dialogue with patie…

Read the full story

Monday, May 21, 2018

FDA Greenlights Restylane Lyft for Hand Rejuvenation

The US Food and Drug Administration has approved Restylane Lyft for use on the dorsal hands of people older than 21, making it the first hyaluronic acid (HA) injectable gel approved for this…

Read the full story

Monday, April 30, 2018

New Phase 4 Data: Epiduo Forte Gel Decreased Acne Lesions, Reduced Risk of Scars

Results from OSCAR, a Phase 4, multicenter, randomized, investigator-blinded, vehicle-controlled, intra-individual comparison study (right/left half-face), revealed that Epiduo Forte (adapalene a…

Read the full story

Tuesday, March 06, 2018

Differin Launches Retinoid Education Week

Differin® has launched Retinoid Education Week to educate the more than 50 million Americans with acne about how retinoids can be used to treat their condition. Part of Nestlé Skin Health&r…

Read the full story

Friday, February 23, 2018

Galderma Enters into Long-term Research Agreement on AD with Icahn School of Medicine at Mount Sinai and Northwestern University Feinberg School of Medicine

Galderma has signed a joint research agreement on Atopic Dermatitis (AD) with two leading academic institutions -- Icahn School of Medicine at Mount Sinai in New York City, and Northwestern University…

Read the full story

Thursday, October 12, 2017

FDA Approves Injection of Restylane Silk via Cannula for Lip Augmentation

The FDA has approved the use of a small blunt tip cannula with Galderma's Restylane Silk for lip augmentation. Restylane Silk was the first FDA-approved hyaluronic acid (HA) dermal filler specific…

Read the full story

Friday, September 15, 2017

Happy 70th Cetaphil!

Cetaphil is turning 70! To celebrate this milestone birthday, which takes place on Sept. 19, Cetaphil will launch a series of initiatives including: A 70-hour flash sale across retail partner…

Read the full story

Monday, September 11, 2017

Two Galderma Rosacea Therapies Work Well Together

Combined use of Galderma’s SOOLANTRA (ivermectin1% Cream) and Mirvaso (Brimonidine 0.33% Gel) pack a one-two punch against the erythema and inflammatory lesions of rosacea, the MirvasO Soolantra…

Read the full story

Thursday, September 07, 2017

Galderma Names New Managers of Prescription Business and Aesthetic & Corrective Business Units; Dr. Kelly Huang to Obalon

Galdmera has named new managers of its Prescription Business and Aesthetic & Corrective Business units in the United States. Chris Chapman is Galderma’s new Vice President and General Manage…

Read the full story

Monday, July 17, 2017

Galderma CareConnect Patient Savings Card Program Passes Milestone

The Galderma CareConnect patient savings program has surpassed the mark of 1,000,000 prescriptions filled through its patient access program. Committed to keeping accessibility remarkably simple and s…

Read the full story

Monday, July 17, 2017

Patent Challenge Filed for Generic Version Of Soolantra Cream

Perrigo Company plc's subsidiary has filed a Paragraph IV Abbreviated New Drug Application with the FDA for a generic version of Soolantra® (ivermectin) cream, 1%. Following notification fr…

Read the full story

Wednesday, July 05, 2017

Study: Soolantra is Both Anti-Inflammatory and Anti-Demodex

A recently published study sought to find scientific rationale for the dual anti-inflammatory and anti-parasitic mode of action of topical ivermectin 1% cream (Soolantra) in patients with rosacea. …

Read the full story
Load More